https://www.selleckchem.com/pr....oducts/lixisenatide.
To elucidate whether DNA aneuploidy was an independent discriminator for carcinoma within oral potentially malignant disorders (OPMDs), and further establish and validate a risk model based on DNA aneuploidy for the detection of oral cancer. A total of 810 consecutive patients with OPMD were prospectively enrolled from March 2013 to December 2018, and divided into a training set ( = 608) and a test set ( = 202). Brushing and biopsy samples from each patient were processed by DNA-DNA image cytometry and histopathological examination
Like
Comment
Share
